CDMO – Page 3 – Talk Bio

Actionable Insights Powered by AI

Rovi Receives Acquisition Offers for CDMO Unit Worth €2B to €3B

1 year ago talkbio0Tagged Acquisition (action), Biogen, CDMO, Private Equity, Rovi

Rovi, CDMO, Acquisition Offers, Private Equity, Biogen, Deal Making

GenScript ProBio Launches New Gene Therapy Production Plant in New Jersey

1 year ago talkbio0Tagged biotech, CDMO, gene therapy, GenScript ProBio, Plants, production

GenScript ProBio, Gene Therapy, Production Plant, New Jersey, CDMO, Biotech

Bionova Scientific Expands into Plasmid DNA Services for Cell and Gene Therapy Developers

1 year ago talkbio0Tagged Asahi Kasei, Biological Factors, Bionova, CDMO, Cells, DNA, Facility (object), gene therapy, Plasmids, Science, Texas

Bionova Scientific, Plasmid DNA, Cell and Gene Therapy, CDMO, Asahi Kasei Group, Biopharmaceuticals, Biologics, Texas Facility

Merck KGaA Remains Optimistic About CDMO Business Prospects Amidst Q1 Downturn

1 year ago talkbio0Tagged business career, CDMO, Drug Industry, first-quarter, Merck KGaA, Optimism, slump

Merck KGaA, CDMO, first-quarter, slump, optimism, business prospects, pharmaceutical industry.

Fujifilm Diosynth’s Restructuring Plan May Leave 240 Employees Jobless

1 year ago talkbio0Tagged CDMO, Contract Development, Fujifilm Diosynth, Loss of job, Manufacturing Organization, Restructuring plan, staffers

Fujifilm Diosynth, CDMO (Contract Development and Manufacturing Organization), Restructuring plan, Potential job loss, 240 staffers